Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AgeX Therapeutics, Inc. (AGE)

0.5707   -0.006 (-0.95%) 07-02 18:55
Open: 0.6019 Pre. Close: 0.5762
High: 0.6019 Low: 0.5632
Volume: 46,153 Market Cap: 22(M)
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550, a gene delivery technology. The company has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.61 - 0.61 0.61 - 0.62
Low: 0.55 - 0.55 0.55 - 0.55
Close: 0.55 - 0.55 0.55 - 0.56

Technical analysis

as of: 2022-07-01 4:19:53 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.82     One year: 0.94
Support: Support1: 0.55    Support2: 0.46
Resistance: Resistance1: 0.7    Resistance2: 0.8
Pivot: 0.61
Moving Average: MA(5): 0.57     MA(20): 0.65
MA(100): 0.76     MA(250): 0.86
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 7.2     %D(3): 6.6
RSI: RSI(14): 39
52-week: High: 1.55  Low: 0.51
Average Vol(K): 3-Month: 42 (K)  10-Days: 29 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AGE ] has closed above bottom band by 25.2%. Bollinger Bands are 3.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 02 Jul 2022
UCSC Breaks Canadian Age Group Relay Record Set in 2009 By an Olympian & WR Holder - SwimSwam

Sat, 02 Jul 2022
I Used AI Technology On 26 Older Celebrities To See How Accurately It Aged Them, And It's Scary To See - BuzzFeed

Sat, 02 Jul 2022
New BioWare Update Is Good News for Mass Effect and Dragon Age Fans - ComicBook.com

Sat, 02 Jul 2022
The Age of Singlehood Is Coming to Asia - Psychology Today

Sat, 02 Jul 2022
Sounding off: Raising age to buy a gun won't stop violence - TribLIVE

Sat, 02 Jul 2022
BioWare Fans Are Wondering What Dragon Age 2 Should Have Been Called - TheGamer

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 38 (M)
Shares Float 18 (M)
% Held by Insiders 43.4 (%)
% Held by Institutions 17.9 (%)
Shares Short 432 (K)
Shares Short P.Month 404 (K)

Stock Financials

EPS -0.24
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.26
Profit Margin (%) 0
Operating Margin (%) -520
Return on Assets (ttm) -174.7
Return on Equity (ttm) 0
Qtrly Rev. Growth -65.2
Gross Profit (p.s.) 0.04
Sales Per Share 0.04
EBITDA (p.s.) -0.23
Qtrly Earnings Growth 0
Operating Cash Flow -8 (M)
Levered Free Cash Flow -5 (M)

Stock Valuations

PE Ratio -2.41
PEG Ratio 0
Price to Book value -2.2
Price to Sales 12.16
Price to Cash Flow -2.77

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.